JOURNAL OF HEART AND LUNG TRANSPLANTATION

Scope & Guideline

Elevating Research in Cardiology and Respiratory Medicine

Introduction

Welcome to the JOURNAL OF HEART AND LUNG TRANSPLANTATION information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JOURNAL OF HEART AND LUNG TRANSPLANTATION, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1053-2498
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1991 to 2024
AbbreviationJ HEART LUNG TRANSPL / J. Heart Lung Transplant.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

The Journal of Heart and Lung Transplantation focuses on advancing the science and practice of organ transplantation, particularly concerning heart and lung procedures. It aims to disseminate groundbreaking research, clinical experiences, and consensus guidelines that shape the future of transplantation practices.
  1. Clinical Outcomes and Patient Management:
    The journal emphasizes studies related to clinical outcomes in heart and lung transplant recipients, focusing on patient management strategies, post-operative care, and long-term follow-up.
  2. Innovative Transplant Techniques and Technologies:
    It highlights advancements in surgical techniques, mechanical circulatory support devices, and organ preservation technologies, showcasing how these innovations improve transplantation success.
  3. Immunology and Rejection Mechanisms:
    Research related to immune responses, including antibody-mediated rejection and the role of different immunosuppressive therapies, is a core focus, exploring how these factors influence graft survival.
  4. Socioeconomic and Racial Disparities:
    The journal addresses disparities in transplantation outcomes based on socioeconomic status and race, aiming to bring attention to inequalities in access to transplant services.
  5. Emerging Therapies and Biomarkers:
    It includes studies on new therapeutic approaches, biomarker identification for predicting rejection, and monitoring graft health, contributing to personalized medicine in transplantation.
The Journal of Heart and Lung Transplantation has been at the forefront of several emerging themes that reflect the current trends in transplantation science and practice. These trends highlight the journal's commitment to addressing contemporary challenges and innovations in the field.
  1. Donor-Derived Cell-Free DNA Monitoring:
    The use of donor-derived cell-free DNA as a biomarker for graft health and rejection surveillance has gained prominence, reflecting an increasing interest in non-invasive monitoring techniques.
  2. Telehealth and Remote Monitoring:
    With the rise of digital health, studies exploring telehealth applications for monitoring transplant recipients and improving patient engagement are trending, particularly in the context of the COVID-19 pandemic.
  3. Holistic Approaches to Patient Care:
    There is a growing emphasis on the psychosocial aspects of transplantation, including caregiver support, mental health interventions, and quality of life assessments for patients.
  4. Personalized Medicine in Transplantation:
    Research focused on tailoring immunosuppressive therapies based on individual patient and donor characteristics is emerging as a crucial area, promoting better outcomes.
  5. Integration of Machine Learning and AI in Transplantation:
    The application of machine learning models to predict transplant outcomes and assess risk factors is becoming increasingly popular, facilitating data-driven decision-making in clinical practice.

Declining or Waning

As the field of organ transplantation evolves, certain themes within the Journal of Heart and Lung Transplantation have shown a decline in focus. This could reflect shifts in clinical priorities, research funding, or advancements in technology that render previously critical areas less prominent.
  1. Traditional Immunosuppression Protocols:
    There is a noticeable decrease in studies focused solely on traditional immunosuppressive regimens, as newer therapies and personalized approaches gain traction.
  2. Longitudinal Studies on Aging Donor Organs:
    Research centered on the aging of donor organs and its effects on transplantation outcomes appears to be waning, possibly overshadowed by advancements in organ preservation and procurement techniques.
  3. Basic Science Studies on Transplant Immunology:
    While fundamental research remains important, there has been a shift towards clinical applications and practical outcomes, resulting in fewer basic science studies being published.
  4. Single-Center Studies:
    As multicenter collaborations become more common, the focus on single-center studies is declining, likely due to the need for broader data to support findings.
  5. Historical Case Studies and Anecdotal Evidence:
    The journal has seen a reduction in the publication of historical case studies as the focus shifts to evidence-based practices and current clinical guidelines.

Similar Journals

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Advancing surgical excellence in thoracic and cardiovascular care.
Publisher: MOSBY-ELSEVIERISSN: 0022-5223Frequency: 12 issues/year

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, published by Mosby-Elsevier, stands as a leading peer-reviewed journal dedicated to advancing the fields of thoracic and cardiovascular surgery. With an impressive impact factor reflecting its rigorous standards and significance, this journal occupies prestigious Q1 quartiles in 2023 across Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, as well as Surgery. Additionally, it boasts remarkable rankings in the Scopus database, being placed at #8 in Surgery and #29 in Cardiology and Cardiovascular Medicine, underscoring its pivotal role in disseminating high-quality research and clinical insights. Its scope encompasses vital areas such as surgical techniques, innovative therapies, and patient outcomes, making it an essential resource for researchers, clinicians, and students passionate about advancing cardiac and pulmonary health. Though not an open-access journal, it ensures that subscribers and institutional partners can access valuable research contributions published within its pages from 1959 to 2024. The JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY continues to shape the future of surgical practices and enhance patient care on a global scale.

TRANSPLANT INTERNATIONAL

Fostering Collaboration for Safer Organ Transplants
Publisher: FRONTIERS MEDIA SAISSN: 0934-0874Frequency: 1 issue/year

TRANSPLANT INTERNATIONAL is a premier open-access journal in the field of transplantation, published by Frontiers Media SA since 1988. With its dedicated scope encompassing the latest research and advancements in organ transplantation and related fields, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals engaged in transplantation medicine. Boasting an impressive 2023 Scopus rank of #17 out of 54 in the Medicine - Transplantation category and a Q2 quartile ranking, it has established itself as a vital publication platform contributing to the global discourse on transplant innovations. As an open-access journal since 2022, TRANSPLANT INTERNATIONAL enhances the dissemination of knowledge, ensuring that pivotal findings are accessible to a broader audience, thereby fostering advancements in patient care and clinical practices. With its base in Italy and operations managed from Lausanne, Switzerland, the journal promises to remain at the forefront of transplantation research through 2024 and beyond.

Journal of Transplantation

Empowering Research in Transplantation and Immunology
Publisher: HINDAWI LTDISSN: 2090-0007Frequency: 1 issue/year

The Journal of Transplantation is a leading peer-reviewed journal published by HINDAWI LTD, dedicated to advancing the field of organ transplantation and associated medical research. Since its inception in 2009 as an Open Access journal, it has provided a vital platform for researchers, clinicians, and students to share innovative findings and developments in transplantation science. With an emphasis on high-quality research, the journal aims to publish original articles, reviews, and case studies that contribute to the understanding of immunology, surgical techniques, and postoperative care, thereby enhancing patient outcomes. The journal is committed to fostering a collaborative scientific community and making valuable research freely accessible to professionals worldwide, ensuring that it remains at the forefront of transplantation studies. This journal serves as an essential resource for anyone looking to stay updated on the latest advancements and clinical practices in the field.

Current Opinion in Organ Transplantation

Advancing Insights in Organ Transplantation
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1087-2418Frequency: 6 issues/year

Current Opinion in Organ Transplantation, published by Lippincott Williams & Wilkins, serves as a leading journal in the fields of immunology and transplantation, providing insightful reviews and expert opinions that shape the discourse in these vital areas of medical research. With an impact factor showcasing its significance and influence in the academic community, this journal is ranked in the Q2 category for both Immunology and Transplantation according to the 2023 metrics, affirming its essential role in advancing knowledge and understanding. Spanning from its inception in 2001 through to 2024, Current Opinion in Organ Transplantation offers a platform for researchers, professionals, and students to engage with the latest advancements and trends, contributing to the ongoing dialogue that drives innovation in organ transplantation and immunological therapies. Although the journal does not currently offer open access options, its rigorous peer-review process and reputable publisher ensure the highest quality of research dissemination, making it an invaluable resource for those invested in the future of organ transplantation.

International Journal of Organ Transplantation Medicine

Championing Open Access to Transplantation Breakthroughs
Publisher: AVICENNA ORGAN TRANSPLANT CENTERISSN: 2008-6490Frequency: 4 issues/year

The International Journal of Organ Transplantation Medicine, published by the Avicenna Organ Transplant Center, stands as a vital resource for the field of transplantation medicine. Established to advance scientific knowledge and clinical practices, this open access journal has been supporting the global research community since 2010, ensuring that groundbreaking findings are easily accessible to researchers, professionals, and students alike. With its ISSN of 2008-6490 and E-ISSN 2008-6482, the journal consistently showcases high-quality, peer-reviewed articles, addressing critical advancements in transplantation techniques, patient care, and immunology. Renowned for its commitment to excellence, it holds a Q3 ranking in transplantation for 2023 and ranks #32 out of 54 in the Scopus medicine transplantation category, placing it in the 41st percentile. Researchers are encouraged to submit their work, contributing to the journal's goal of improving outcomes in organ transplantation and fostering collaboration across disciplines.

Expert Review of Respiratory Medicine

Unraveling Innovations in Respiratory Care
Publisher: TAYLOR & FRANCIS LTDISSN: 1747-6348Frequency: 6 issues/year

Expert Review of Respiratory Medicine is a leading journal published by Taylor & Francis Ltd, dedicated to advancing the field of respiratory medicine through evidence-based research and comprehensive reviews. With a robust ISSN of 1747-6348 and an E-ISSN of 1747-6356, the journal disseminates essential insights into pulmonary and respiratory health, ranking an impressive #33 in Medicine - Pulmonary and Respiratory Medicine on Scopus, reflecting its significant contribution to this discipline. Established in 2007 and extending its reach through 2024, Expert Review of Respiratory Medicine serves as a crucial resource for professionals and researchers dedicated to improving respiratory health outcomes. Though not designated as an open-access journal, its impactful articles are pivotal in shaping clinical practices and guiding future research in respiratory medicine and related fields, including public health and immunology. By engaging with this journal, readers can stay abreast of the latest developments and critically evaluate advancements in respiratory care.

Transplant Immunology

Connecting Theory and Practice in Transplant Immunology.
Publisher: ELSEVIERISSN: 0966-3274Frequency: 6 issues/year

Transplant Immunology is a leading interdisciplinary journal published by Elsevier, dedicated to the advancing field of transplant science and immunology. With a strong reputation in the academic community, it currently holds a significant position in the Q3 quartile in both the Immunology and Allergy categories, as well as Q2 in Transplantation, reflecting its impact and relevance within these fields. Since its inception in 1993, the journal has explored a broad spectrum of topics, ranging from immunological mechanisms to clinical aspects of transplantation, serving as a vital resource for researchers, healthcare professionals, and students alike. Although it is not an open-access journal, it offers critical insights and innovative research findings that bridge theoretical knowledge and practical application, thereby enhancing our understanding of transplant immunology. As the field continues to evolve, Transplant Immunology remains committed to publishing high-quality studies that advance the dialogue between immunology and transplantation, fostering collaboration and discovery.

JTO Clinical and Research Reports

Innovating Solutions in Oncology and Pulmonary Health
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

JTO Clinical and Research Reports is an esteemed open-access journal published by Elsevier, dedicated to advancing knowledge in the fields of Oncology and Pulmonary and Respiratory Medicine. Since its inception in 2020, the journal has rapidly gained recognition, achieving a commendable Q1 ranking in both fields as of 2023, highlighting its significant contribution to high-quality research and clinical practice. With an inclusive global reach, JTO Clinical and Research Reports fosters collaboration by allowing unrestricted access to its content, ensuring that vital research findings can be disseminated widely among researchers, clinicians, and students alike. Located in the United States, and with its editorial base in the Netherlands, this journal not only embraces the mission of open science but also strives to publish impactful studies that address critical challenges in cancer treatment and respiratory health. Through its rigorous peer-review process and commitment to excellence, JTO Clinical and Research Reports aims to be at the forefront of scientific discourse and innovation in these dynamic areas of medicine.

HEART & LUNG

Exploring the Frontiers of Cardiovascular and Respiratory Medicine
Publisher: MOSBY-ELSEVIERISSN: 0147-9563Frequency: 6 issues/year

HEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.

Experimental and Clinical Transplantation

Innovating the Future of Transplantation and Immunology
Publisher: BASKENT UNIVISSN: 1304-0855Frequency: 6 issues/year

Experimental and Clinical Transplantation is a distinguished journal published by Baskent University in Turkey, dedicated to advancing the field of transplantation through innovative research and clinical insights. Established in 2003, the journal has rapidly gained recognition within the academic community, currently holding a Q3 ranking in the field of Transplantation for 2023, as evidenced by its position in the Scopus ranking for the discipline. With an emphasis on both experimental and clinical studies, this journal serves as a crucial platform for sharing breakthroughs in transplant medicine, immunology, and post-operative care strategies. Although it operates under a restricted access policy, the journal seeks to bridge the gap between research findings and practical applications in clinical settings, making it invaluable for researchers, healthcare professionals, and students alike who are keen on exploring advancements in the transplantation landscape. Through its commitment to quality and innovation, Experimental and Clinical Transplantation contributes significantly to enhancing patient outcomes and fostering scholarly dialogue in the transplantation community.